Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 634,700 | 622,800 | 642,100 | 428,700 | 628,400 |
| Receivables | 1,761,100 | 1,872,500 | 1,784,800 | 1,680,700 | 1,758,000 |
| Inventories | 1,306,000 | 1,340,500 | 1,287,000 | 1,171,000 | 1,167,000 |
| Other current assets | 385,400 | 421,400 | 374,300 | 338,100 | 382,400 |
| TOTAL | $4,087,200 | $4,257,200 | $4,088,200 | $3,618,500 | $3,935,800 |
| Non-Current Assets | |||||
| PPE Net | 3,047,200 | 3,149,300 | 3,082,300 | 3,015,200 | 2,831,700 |
| Intangibles | 3,048,100 | 3,264,600 | 3,252,900 | 3,116,800 | 3,072,000 |
| Other Non-Current Assets | 372,700 | 399,201 | 386,000 | 361,500 | 244,200 |
| TOTAL | $6,468,000 | $6,813,101 | $6,721,200 | $6,493,500 | $6,147,900 |
| Total Assets | $10,555,200 | $11,070,300 | $10,809,400 | $10,112,000 | $10,083,700 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 140,100 | 138,900 | 139,400 | 138,100 | 637,100 |
| Accounts payable and accrued liabilities | 1,096,000 | 1,167,600 | 1,130,900 | 1,066,800 | 1,036,000 |
| TOTAL | $3,255,800 | $3,320,300 | $3,611,200 | $3,162,700 | $3,785,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,284,400 | 3,475,900 | 3,407,800 | 3,221,900 | 2,750,100 |
| Other Non-Current Liabilities | 1,142,700 | 1,239,000 | 1,221,600 | 1,177,100 | 1,273,600 |
| TOTAL | $4,831,500 | $5,083,400 | $4,946,000 | $4,663,100 | $4,276,500 |
| Total Liabilities | $8,087,300 | $8,403,700 | $8,557,200 | $7,825,800 | $8,061,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,009,430 | 1,011,465 | 1,015,618 | 1,019,642 | 1,019,524 |
| Common Shares | 732,900 | 732,900 | 732,900 | 732,900 | 732,900 |
| Retained earnings | 11,480,900 | 11,185,600 | 10,704,700 | 10,627,500 | 10,411,800 |
| Other shareholders' equity | -2,012,500 | -1,672,900 | -1,787,800 | -1,885,400 | -2,100,700 |
| TOTAL | $2,467,900 | $2,666,600 | $2,252,200 | $2,286,200 | $2,022,100 |
| Total Liabilities And Equity | $10,555,200 | $11,070,300 | $10,809,400 | $10,112,000 | $10,083,700 |